Hematologic Disorders

ASH has named four new members to its executive committee beginning immediately after the 2024 ASH Annual Meeting.

The amount of autologous and allogeneic hematopoietic stem cell transplants for hematologic disorders has increased over time in tandem with longer survival, according to results of an observational study.